Skip to main
XYL

Xylem (XYL) Stock Forecast & Price Target

Xylem (XYL) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 45%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

Xylem has demonstrated robust financial performance, achieving 7% organic revenue growth and expanding margins by 200 basis points in the third quarter of 2025, highlighting the company's strong operational efficiency. The company's sales of $656.0 million in 3Q25 reflect a 5.3% year-over-year increase, driven significantly by treatment solutions and strong demand across various sectors, including commercial buildings and utilities. With a presence in over 150 countries and anticipated mid-single-digit organic growth in the M&CS segment for 2026, Xylem is well-positioned to capitalize on ongoing market demand for water technology solutions.

Bears say

Xylem's recent earnings report revealed a slight miss in 2026 earnings per share guidance, coupled with concerns of ongoing softness in the Chinese market, which is expected to limit revenue growth in the first half of 2026. The company's anticipated low single-digit revenue decline for 1Q26 and challenges related to project timing, particularly in the UK's AMP 8 cycle, indicate a lack of immediate growth momentum. Additionally, the implementation of 80-20 simplification initiatives, while aimed at fostering efficiency, is forecasted to dampen overall segment growth, contributing to a cautious outlook on Xylem's financial performance.

Xylem (XYL) has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 45% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Xylem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Xylem (XYL) Forecast

Analysts have given Xylem (XYL) a Buy based on their latest research and market trends.

According to 11 analysts, Xylem (XYL) has a Buy consensus rating as of Apr 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $155.55, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $155.55, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Xylem (XYL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.